ArticleLeukemia2023

Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression.

Margot F van Spronsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.